Biotechnology & Medical Research
Coherus Biosciences files for offering of upto 6.56 million shares of common stock by the selling stockholder
Sept 22 (Reuters) - Coherus Biosciences Inc
Auris Medical completes patient recruitment for phase 3 trial of Keyzilen in acute and post-acute tinnitus
Sept 22 (Reuters) - Auris Medical Holding Ag
Sept 22 (Reuters) - Avista Capital Ii [RIC:RIC:AVAAA.UL]:Avista Capital Partners says Miraca Life Sciences is a wholly-owned subsidiary of Miraca Holdings Inc.
Sept 22 (Reuters) - Miraca Holdings Inc <4544.T>:Says co's unit Miraca Life Sciences Inc's parent company CDx Holdings Inc (CDx) will merge with Avista Capital Holdings LP's unit Symphony Merger Sub Inc (Merger Sub) to become one company (CDx & Merger Sub).Says co will hold 15 percent stake in new holding company Symphony Buyer Inc, which will indirectly hold 100 percent in CDx & Merger Sub.Says co will cut all stake in unit Miraca Life Sciences Inc after the merger in November .Says transaction amount is $175.6 million .